UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 74 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $16,000 | -74.6% | 11,000 | -47.6% | 0.00% | -72.7% |
| Q3 2021 | $63,000 | -71.4% | 21,000 | -49.9% | 0.01% | -77.6% |
| Q4 2020 | $220,000 | +40.1% | 41,950 | -7.7% | 0.05% | +19.5% |
| Q3 2020 | $157,000 | -15.6% | 45,450 | +111.9% | 0.04% | -24.1% |
| Q2 2020 | $186,000 | -38.2% | 21,450 | -58.7% | 0.05% | -50.0% |
| Q1 2020 | $301,000 | -50.0% | 51,950 | -37.7% | 0.11% | -41.9% |
| Q4 2019 | $602,000 | +886.9% | 83,450 | +734.5% | 0.19% | +830.0% |
| Q3 2019 | $61,000 | -62.3% | 10,000 | -41.2% | 0.02% | -63.0% |
| Q2 2019 | $162,000 | – | 17,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |